NCT01156298View on ClinicalTrials.gov

Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance

TerminatedOBSERVATIONAL
Enrollment

383

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions
Multiple Sclerosis
Trial Locations (1)

14203

Research Site, Buffalo

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY